Founder Mark Kiel comments on today’s news of the acquisition of leading genomics interpretation and curation company, Boston Genetics, and what it means for the race to curate the human genome.
Last week, I was in Los Angeles for ASHG. It was great to return in person after the pandemic pause to exchange ideas with industry and academic leaders in genetics. There is something irreplaceable about speaking face-to-face to make real connections and have lively discussions.
Last month’s World Orphan Drug Congress brought together more than 250 insightful speakers, including a key leader from Rady Children’s Hospital who focused on the new new BeginNGS™ (pronounced “beginnings”) program, based at the Rady Children’s Institute for Genomic Medicine (RCIGM).
Earlier this month, I wrote an opinion article for Technology Networks on how a combination of both human and artificial intelligence technologies have the potential to expedite curation of the entire human genome – and how Genomenon is uniquely suited to address this important challenge.
The Keck Graduate Institute Industry Speaker Series helps students explore career options in the life sciences industry by engaging the expertise of professionals from their expansive network. In this blog, Genomenon founder and chief science officer Dr. Mark Kiel summarizes the important lessons he has learned throughout his inspiring transition from academia to entrepreneurship.
Disease-Specific Curated Content, now available to everyone in the Mastermind Genomic Search Engine, presents comprehensive and expertly curated variant data to provide clinical diagnostic labs with certainty, consistency, and confidence. This blog will guide you through the key benefits of this new offering, including an informative video tutorial.